| |
| Device | ARTIFICIAL PANCREAS DEVICE SYSTEM, THRESHOLD SUSPEND |
| Generic Name | Automated insulin dosing , threshold suspend |
| Applicant | Medtronic, Inc. 18000 Devonshire St. Northridge, CA 91325 |
| PMA Number | P120010 |
| Supplement Number | S082 |
| Date Received | 12/28/2015 |
| Decision Date | 01/27/2016 |
| Product Code |
OZO |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01112696
|
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement THE APPROVAL OF A TRANSITION OF THE MANUFACTURING OF THE TYVEK LIDS USED FOR PACKAGING THE ENLITE SENSOR COMPONENT FROM THE SUPPLIER'S FACILITY IN PHILADELPHIA TO OSHKOSH, WISCONSIN. ADDITIONALLY, THE FACILITY TRANSITION INCLUDES NEW MANUFACTURING ASSETS INCLUDING COATER AND DIE CUT LID PRESS. THE ENLITE SENSOR IS A COMPONENT OF THE MINIMED 530G SYSTEMS. |
| Post-Approval Study | Show Report Schedule and Study Progress |